Naperville, IL -- (SBWIRE) -- 02/13/2014 -- Reportstack, provider of premium market research reports announces the addition of Avanir Pharmaceuticals, Inc. - Product Pipeline Review - 2014 market report to its offering
Avanir Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Summary
Global Market Directs pharmaceuticals report, Avanir Pharmaceuticals, Inc. - Product Pipeline Review - 2014 provides data on the Avanir Pharmaceuticals, Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from proprietary databases, Avanir Pharmaceuticals, Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Avanir Pharmaceuticals, Inc. and industry-specific third party sources, put together by team.
Scope
- Avanir Pharmaceuticals, Inc. - Brief Avanir Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Avanir Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Avanir Pharmaceuticals, Inc. with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Avanir Pharmaceuticals, Inc.s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Avanir Pharmaceuticals, Inc.s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Avanir Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Avanir Pharmaceuticals, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Avanir Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Avanir Pharmaceuticals, Inc. and identify potential opportunities in those areas.
To view the table of contents for this market research report please visit
http://www.reportstack.com/product/150508/avanir-pharmaceuticals-inc-product-pipeline-review-2014.html
Contact:
Roger Campbell
contactus@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604
###